CLINICAL_TRIALS
trial_result
· 2022-07-12
Clinical Trial Update: Letrozole as a Prophylaxis From GTN for Complete Mole Patients [Phase 2, Phase 3]
Summary
Clinical trial update on using letrozole as prophylaxis for GTN in patients with complete mole disease, spanning Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zagazig University | Conditions: Gestational Trophoblastic Disease | Phase 2, Phase 3 | Status: UNKNOWN